Clinical and biochemical footprints of inherited metabolic diseases. II. Metabolic liver diseases.

Carlos R Ferreira, David Cassiman, Nenad Blau

Journal: Molecular genetics and metabolism 2020;127(2):117-121

PMID: 31005404

Abstract

Inherited metabolic diseases account for about one third of pediatric patients with hepatomegaly, acute liver failure, cirrhosis or cholestasis. Specifically for pediatric acute liver failure, they account for 10-15% of cases, with a mortality of 22-65%. The percentage of acute liver failure caused by an inherited metabolic disease in children <2-3 years of age is even higher, ranging from a third to half of all cases. Metabolic liver disease accounts for 8-13% of all pediatric liver transplantations. Despite this high burden of disease, underdiagnosis remains common. We reviewed and updated the list of known metabolic etiologies associated with various types of metabolic liver involvement, and found 142 relevant inborn errors of metabolism. This represents the second of a series of articles attempting to create and maintain a comprehensive list of clinical and metabolic differential diagnoses according to system involvement.

Published by Elsevier Inc.

Address: National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: [email protected].; Department of Gastroenterology-Hepatology and Metabolic Center, University of Leuven, Leuven, Belgium. Electronic address: [email protected].; Dietmar-Hopp Metabolic Center, University Children's Hospital, Heidelberg, Germany; Division of Metabolism, Children's Hospital, Zürich, Switzerland. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.